Home LiteratureArticle Details
PMID: 15109426 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes.

Emerging infectious diseases ·Vol. 10 ·No. 3 ·2004-03-00 ·Pages 514-7

Albrich WC, Monnet DL, Harbarth S

Abstract

We correlated outpatient antibiotic use with prevalence of penicillin-nonsusceptible Streptococcus pneumoniae (PNSP), macrolide-resistant S. pneumoniae (MRSP), and macrolide-resistant S. pyogenes (MRGAS) in 20 countries. Total antibiotic use was correlated with PNSP (r = 0.75; p < 0.001), as was macrolide use with MRSP (r = 0.88; p < 0.001) and MRGAS (r = 0.71; p = 0.004). Streptococcal resistance is directly associated with antibiotic selection pressure on a national level.

MeSH Terms
Anti-Bacterial Agents/administration & dosage,pharmacology,therapeutic use Drug Resistance, Multiple, Bacterial/drug effects Europe Humans Penicillin Resistance Practice Patterns, Physicians' Prevalence Streptococcus pneumoniae/drug effects Streptococcus pyogenes/drug effects United States
Chemicals
Anti-Bacterial Agents
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Albrich Werner C
Emory University School of Medicine, Atlanta, Georgia, USA.
Monnet Dominique L
Harbarth Stephan
References (36)
36 references, click to expand
  1. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.
    N Engl J Med. 1999 Jul 22;341(4):233-9 PMID: 10413735
  2. Increasing prevalence of antimicrobial resistance among isolates of Streptococcus pneumoniae from the PROTEKT surveillance study, and compatative in vitro activity of the ketolide, telithromycin.
    J Antimicrob Chemother. 2002 Sep;50 Suppl S1:25-37 PMID: 12239226
  3. Macrolide resistance and erythromycin resistance determinants among Belgian Streptococcus pyogenes and Streptococcus pneumoniae isolates.
    J Antimicrob Chemother. 2000 Feb;45(2):167-73 PMID: 10660498
  4. The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections.
    J Antimicrob Chemother. 2000 Feb;45(2):191-203 PMID: 10660501
  5. Resistance surveillance of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis isolated in Asia and Europe, 1997-1998.
    J Antimicrob Chemother. 2000 Apr;45(4):457-66 PMID: 10747822
  6. [Antibiotic use and bacterial resistance].
    Ann Fr Anesth Reanim. 2000 May;19(5):409-17 PMID: 10874442
  7. Assessment of the susceptibility of Streptococcus pneumoniae to cefaclor and loracarbef in 13 countries.
    J Chemother. 2000 Aug;12(4):299-305 PMID: 10949979
  8. The evolving threat of antibiotic resistance in Europe: new data from the Alexander Project.
    J Antimicrob Chemother. 2000 Jul;46 Suppl T1:3-9 PMID: 10997593
  9. Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).
    J Clin Microbiol. 2000 Nov;38(11):4298-9 PMID: 11185065
  10. Streptococcus pyogenes resistance to erythromycin in relation to macrolide consumption in Spain (1986-1997).
    J Antimicrob Chemother. 2000 Dec;46(6):959-64 PMID: 11102415
  11. Resistance patterns of lower respiratory tract pathogens in Europe.
    Int J Antimicrob Agents. 2000 Nov;16 Suppl 1:S25-9 PMID: 11137405
  12. Measuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae.
    Clin Infect Dis. 2001 Apr 1;32(7):1044-54 PMID: 11264033
  13. The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens.
    J Antimicrob Chemother. 2001 Apr;47(4):475-7 PMID: 11266425
  14. Variation in antibiotic use in the European Union.
    Lancet. 2001 Jun 9;357(9271):1851-3 PMID: 11410197
  15. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents.
    Clin Infect Dis. 2001 Aug 15;33(4):483-8 PMID: 11462184
  16. Antibiotic use and resistance of Streptococcus pneumoniae in The Netherlands during the period 1994-1999.
    J Antimicrob Chemother. 2001 Sep;48(3):441-4 PMID: 11533014
  17. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli.
    Clin Infect Dis. 2001 Nov 1;33(9):1462-8 PMID: 11588690
  18. Antibiotic usage in Nordic countries.
    Int J Antimicrob Agents. 2001 Sep;18(3):279-82 PMID: 11673043
  19. Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective.
    Emerg Infect Dis. 2002 Dec;8(12):1460-7 PMID: 12498664
  20. Bacterial resistance: origins, epidemiology, and impact.
    Clin Infect Dis. 2003 Jan 15;36(Suppl 1):S11-23 PMID: 12516026
  21. Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States.
    Nat Med. 2003 Apr;9(4):424-30 PMID: 12627227
  22. Antimicrobial resistance in hospital organisms and its relation to antibiotic use.
    Rev Infect Dis. 1983 Nov-Dec;5(6):1033-48 PMID: 6318289
  23. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. Finnish Study Group for Antimicrobial Resistance.
    N Engl J Med. 1997 Aug 14;337(7):441-6 PMID: 9250845
  24. Antibiotic use in the Australian community, 1990-1995.
    Med J Aust. 1997 Aug 4;167(3):124-7 PMID: 9269265
  25. Application of the ATC/DDD methodology to monitor antibiotic drug use.
    Eur J Clin Microbiol Infect Dis. 1998 Jan;17(1):20-4 PMID: 9512177
  26. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain.
    Antimicrob Agents Chemother. 2001 Dec;45(12):3334-40 PMID: 11709305
  27. The prevalence of antibiotic resistance in bacterial respiratory pathogens from Norway is low.
    Clin Microbiol Infect. 2001 Dec;7(12):682-7 PMID: 11843910
  28. Antimicrobial resistance of invasive Streptococcus pneumoniae in Slovenia from 1997 to 2000.
    J Antimicrob Chemother. 2002 Mar;49(3):582-4 PMID: 11864967
  29. Control of multiply resistant cocci: do international comparisons help?
    Lancet Infect Dis. 2001 Nov;1(4):251-61 PMID: 11871512
  30. Invasive pneumococcal infections in Denmark from 1995 to 1999: epidemiology, serotypes, and resistance.
    Clin Diagn Lab Immunol. 2002 Mar;9(2):358-65 PMID: 11874878
  31. A European study on the relationship between antimicrobial use and antimicrobial resistance.
    Emerg Infect Dis. 2002 Mar;8(3):278-82 PMID: 11927025
  32. Macrolide-resistant group a streptococcus--now in the United States.
    N Engl J Med. 2002 Apr 18;346(16):1243-5 PMID: 11961156
  33. Antimicrobial use and antimicrobial resistance: a population perspective.
    Emerg Infect Dis. 2002 Apr;8(4):347-54 PMID: 11971765
  34. Diversity of penicillin-nonsusceptible Streptococcus pneumoniae circulating in Iceland after the introduction of penicillin-resistant clone Spain(6B)-2.
    J Infect Dis. 2002 Oct 1;186(7):966-75 PMID: 12232837
  35. Antimicrobial resistance amongst isolates of Streptococcus pyogenes and Staphylococcus aureus in the PROTEKT antimicrobial surveillance programme during 1999-2000.
    J Antimicrob Chemother. 2002 Sep;50 Suppl S1:9-24 PMID: 12239225
  36. Pneumococcal disease in Sweden: experiences and current situation.
    Am J Med. 1999 Jul 26;107(1A):44S-49S PMID: 10451008
Article Info
Journal
Emerging infectious diseases
Abbr.
Emerg Infect Dis
ISSN
1080-6040
DOI
10.3201/eid1003.030252
Published
2004-03-00
Pages
514-7
Language
English
Region
United States
NLM ID
9508155
PMCID
PMC3322805
Subset
IM
External Links
PubMed source DOI: 10.3201/eid1003.030252 PMC Full Text View journal details
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]

Copyright © 2026.Genelibs Jinan Honghui Biotechnology Co., Ltd. 鲁ICP备20007159号-2